Sera Prognostics (SERA) Other Non-Current Assets (2020 - 2026)
Sera Prognostics (SERA) posted Other Non-Current Assets of $2.5 million for Q1 2026, down 1.94% on a QoQ basis from $2.5 million in Q4 2025, and up 321.09% year-over-year from $588000.0 in Q1 2025.
Sera Prognostics (SERA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Sera Prognostics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 321.09% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 321.09% YoY) and the FY2025 annual result came in at $2.5 million, up 242.61% from the prior year.
- Other Non-Current Assets was $2.5 million for Q1 2026 at Sera Prognostics, down from $2.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.6 million in Q3 2025 and bottomed at $237000.0 in Q3 2022.
- A 5-year average of $1.4 million and a median of $1.5 million in 2023 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 1056.69% in 2022, while the deepest fall reached 87.16% in 2022.
- Sera Prognostics' Other Non-Current Assets stood at $1.8 million in 2022, then sank by 30.78% to $1.3 million in 2023, then plunged by 41.37% to $737000.0 in 2024, then soared by 242.61% to $2.5 million in 2025, then slipped by 1.94% to $2.5 million in 2026.
- Business Quant data shows SERA's Other Non-Current Assets at $2.5 million in Q1 2026, $2.5 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 285.90 Mn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | 2.25 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | 164.00 Mn |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 828.89 Mn |
| 10 | Sera Prognostics | 104.54 Mn | 104.54 Mn | -28,000.00 | 2.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.48 Mn |
| Dec 31, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.58 Mn |
| Jun 30, 2025 | 435,000.00 |
| Mar 31, 2025 | 588,000.00 |
| Dec 31, 2024 | 737,000.00 |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.82 Mn |
| Sep 30, 2022 | 237,000.00 |
| Jun 30, 2022 | 363,000.00 |
| Mar 31, 2022 | 487,000.00 |
| Dec 31, 2021 | 157,000.00 |
| Sep 30, 2021 | 168,000.00 |
| Jun 30, 2021 | 2.83 Mn |